-
MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression.
Mol Cell Biol. 2008 Apr;28(7):2167-74
PMID: 18212054
-
RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response.
Cell Cycle. 2010 Oct 15;9(20):4153-63
PMID: 20948315
-
Allosteric regulation of Argonaute proteins by miRNAs.
Nat Struct Mol Biol. 2010 Feb;17(2):144-50
PMID: 20062058
-
Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function.
Oncogene. 2007 Sep 20;26(43):6307-18
PMID: 17452985
-
Cloning and characterization of human MCM7 promoter.
Gene. 1998 Aug 17;216(1):85-91
PMID: 9714754
-
Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis.
Mol Cell Biol. 2004 Nov;24(21):9527-41
PMID: 15485920
-
Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis.
Mol Cell Biol. 2001 Jul;21(14):4684-99
PMID: 11416145
-
Intrinsic sexually dimorphic expression of the principal human CYP3A4 correlated with suboptimal activation of GH/glucocorticoid-dependent transcriptional pathways in men.
Endocrinology. 2011 Dec;152(12):4813-24
PMID: 21952236
-
Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer.
J Biol Chem. 2012 Mar 9;287(11):7896-906
PMID: 22262832
-
MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
Mol Cancer Res. 2011 Apr;9(4):440-7
PMID: 21454377
-
The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim.
Gastroenterology. 2009 May;136(5):1689-700
PMID: 19422085
-
Colorectal cancer migration and invasion initiated by microRNA-106a.
PLoS One. 2012;7(8):e43452
PMID: 22912877
-
The retinoblastoma tumor suppressor protein.
Adv Cancer Res. 1994;64:25-85
PMID: 7879661
-
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.
Nature. 2010 Jun 24;465(7301):1033-8
PMID: 20577206
-
Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer.
Endocr Relat Cancer. 2011 Apr 28;18(3):333-45
PMID: 21367843
-
Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.
Cancer Res. 2007 Dec 15;67(24):11612-20
PMID: 18089790
-
Control of pRB phosphorylation.
Curr Opin Genet Dev. 1998 Feb;8(1):21-7
PMID: 9529601
-
Cellular mechanisms of tumour suppression by the retinoblastoma gene.
Nat Rev Cancer. 2008 Sep;8(9):671-82
PMID: 18650841
-
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma.
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5003-8
PMID: 21383194
-
Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.
Sci Signal. 2010 Apr 13;3(117):ra29
PMID: 20388916
-
MicroRNAs in cancer: personalizing diagnosis and therapy.
Ann N Y Acad Sci. 2010 Oct;1210:25-33
PMID: 20973796
-
miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8.
Mol Endocrinol. 2012 Jun;26(6):1028-42
PMID: 22556343
-
E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer.
Cancer Cell. 2008 Mar;13(3):272-86
PMID: 18328430
-
MicroRNA involvement in the pathogenesis and management of breast cancer.
J Clin Pathol. 2009 May;62(5):422-8
PMID: 19398594
-
Sialic acid associated with αvβ3 integrin mediates HIV-1 Tat protein interaction and endothelial cell proangiogenic activation.
J Biol Chem. 2012 Jun 8;287(24):20456-66
PMID: 22528484
-
A DNA helicase activity is associated with an MCM4, -6, and -7 protein complex.
J Biol Chem. 1997 Sep 26;272(39):24508-13
PMID: 9305914
-
The retinoblastoma tumor-suppressor gene, the exception that proves the rule.
Oncogene. 2006 Aug 28;25(38):5233-43
PMID: 16936742
-
Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment.
Am J Pathol. 2011 Sep;179(3):1171-8
PMID: 21756866
-
Targeting the RB-pathway in cancer therapy.
Clin Cancer Res. 2010 Feb 15;16(4):1094-9
PMID: 20145169
-
Small RNA-mediated regulation of iPS cell generation.
EMBO J. 2011 Mar 2;30(5):823-34
PMID: 21285944
-
Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma.
Cancer Sci. 2009 Jul;100(7):1234-42
PMID: 19486339
-
Adenosine 2B receptor expression is post-transcriptionally regulated by microRNA.
J Biol Chem. 2010 Jun 11;285(24):18184-90
PMID: 20388705
-
Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure.
Oncogene. 2010 Jul 15;29(28):4018-32
PMID: 20473330
-
Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action.
Cancer Res. 2002 Nov 15;62(22):6587-97
PMID: 12438254
-
Tailoring to RB: tumour suppressor status and therapeutic response.
Nat Rev Cancer. 2008 Sep;8(9):714-24
PMID: 19143056
-
Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.
Cancer Res. 2008 Jul 1;68(13):5104-12
PMID: 18593909
-
MicroRNA-449 and microRNA-34b/c function redundantly in murine testes by targeting E2F transcription factor-retinoblastoma protein (E2F-pRb) pathway.
J Biol Chem. 2012 Jun 22;287(26):21686-98
PMID: 22570483
-
Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors.
Cell Cycle. 2012 Jul 15;11(14):2756-61
PMID: 22767154
-
microRNA involvement in human cancer.
Carcinogenesis. 2012 Jun;33(6):1126-33
PMID: 22491715
-
A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR.
PLoS One. 2008;3(10):e3617
PMID: 18974881
-
The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
Oncogene. 2012 Dec 13;31(50):5162-71
PMID: 22286770
-
Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells.
Nat Cell Biol. 2012 Feb 26;14(3):266-75
PMID: 22366686
-
A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma.
PLoS One. 2012;7(2):e32230
PMID: 22393390
-
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype.
Genome Biol. 2007;8(10):R214
PMID: 17922911
-
Proliferation and tumorigenesis of a murine sarcoma cell line in the absence of DICER1.
Cancer Cell. 2012 Jun 12;21(6):848-55
PMID: 22698408
-
The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas.
Breast Cancer Res. 2008;10(5):R75
PMID: 18782450
-
MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells.
PLoS Genet. 2012;8(6):e1002751
PMID: 22685420
-
Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6.
J Med Chem. 2005 Apr 7;48(7):2388-406
PMID: 15801831
-
Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.
Histopathology. 2005 Mar;46(3):307-13
PMID: 15720416